L3VLUP
ProSign in

ARCT · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ARCTJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ARCT
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterARCTJNJ
Q3 20205 holders, $129m30 holders, $26.2bn
Q4 20201 holders, $172m32 holders, $26.6bn
Q1 20213 holders, $150m31 holders, $25.3bn
Q2 20211 holders, $98m37 holders, $25.6bn
Q3 20213 holders, $128m40 holders, $24.1bn
Q4 20212 holders, $93m33 holders, $25.2bn
Q1 20223 holders, $77m35 holders, $28.2bn
Q2 20223 holders, $61m33 holders, $26.9bn
Q3 20222 holders, $45m36 holders, $25.4bn
Q4 20222 holders, $47m35 holders, $27.6bn
Q1 20232 holders, $67m42 holders, $24.5bn
Q2 20232 holders, $85m38 holders, $25.0bn
Q3 20233 holders, $76m37 holders, $18.9bn
Q4 20234 holders, $111m31 holders, $19.0bn
Q1 20244 holders, $100m32 holders, $19.7bn
Q2 20243 holders, $73m35 holders, $20.4bn
Q3 20244 holders, $77m28 holders, $22.3bn
Q4 20244 holders, $62m37 holders, $20.4bn
Q1 20253 holders, $38m32 holders, $20.5bn
Q2 20253 holders, $43m31 holders, $18.4bn
Q3 20252 holders, $47m32 holders, $23.7bn
Q4 20251 holders, $16m29 holders, $27.8bn
Q1 20261 holders, $21m34 holders, $35.6bn
Q2 20261 holders, $19m33 holders, $39.1bn
ARCT

Arcturus Therapeutics LTD

Holders
4
Reported value
$100m
Buyers
1
Sellers
3

Breadth -2 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
JNJ

Johnson & Johnson

Holders
32
Reported value
$19.7bn
Buyers
16
Sellers
13

Breadth +3 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2024

Among the 34 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ARCT (2)

ARK Investment Management LLC, Schonfeld Strategic Advisors LLC

Only JNJ (30)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Renaissance Technologies LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Two Sigma Investments LP, and 5 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →